APO Research
Talk to an analyst

APO RESEARCH · REPORT

Subcutaneous Injection Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Subcutaneous Injection Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025175 pages

Choose your research edition.

Industry ResearchSubcutaneous Injection Immunoglobulin Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Subcutaneous Injection Immunoglobulin Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Subcutaneous Injection Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Subcutaneous Injection Immunoglobulin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Subcutaneous Injection Immunoglobulin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Subcutaneous Injection Immunoglobulin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Subcutaneous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Subcutaneous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Subcutaneous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Subcutaneous Injection Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Subcutaneous Injection Immunoglobulin include Takeda, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Subcutaneous Injection Immunoglobulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Subcutaneous Injection Immunoglobulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Subcutaneous Injection Immunoglobulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Subcutaneous Injection Immunoglobulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Subcutaneous Injection Immunoglobulin Segment by Company

Takeda

Grifols

CSL

Subcutaneous Injection Immunoglobulin Segment by Type

10% Purity

20% Purity

Subcutaneous Injection Immunoglobulin Segment by Application

Primary Immunodeficiency

Secondary Immunodeficiency

Others

Subcutaneous Injection Immunoglobulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Subcutaneous Injection Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Subcutaneous Injection Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Subcutaneous Injection Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Subcutaneous Injection Immunoglobulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Subcutaneous Injection Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Subcutaneous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Subcutaneous Injection Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Subcutaneous Injection Immunoglobulin Industry Trends Table 2. Subcutaneous Injection Immunoglobulin Industry Drivers Table 3. Subcutaneous Injection Immunoglobulin Industry Opportunities and Challenges Table 4. Subcutaneous Injection Immunoglobulin Industry Restraints Table 5. Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Subcutaneous Injection Immunoglobulin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Manufacturers Table 9. Global Subcutaneous Injection Immunoglobulin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Subcutaneous Injection Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Subcutaneous Injection Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Subcutaneous Injection Immunoglobulin Manufacturers, Product Type & Application Table 13. Global Subcutaneous Injection Immunoglobulin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Subcutaneous Injection Immunoglobulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10% Purity Table 17. Major Manufacturers of 20% Purity Table 18. Global Subcutaneous Injection Immunoglobulin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Subcutaneous Injection Immunoglobulin Sales by Type (2021-2026) & (k units) Table 20. Global Subcutaneous Injection Immunoglobulin Sales by Type (2027-2032) & (k units) Table 21. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2021-2026) Table 22. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2027-2032) Table 23. Global Subcutaneous Injection Immunoglobulin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2021-2026) & (k units) Table 25. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2027-2032) & (k units) Table 26. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2021-2026) Table 27. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Primary Immunodeficiency Table 29. Major Manufacturers of Secondary Immunodeficiency Table 30. Major Manufacturers of Others Table 31. Global Subcutaneous Injection Immunoglobulin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Subcutaneous Injection Immunoglobulin Sales by Application (2021-2026) & (k units) Table 33. Global Subcutaneous Injection Immunoglobulin Sales by Application (2027-2032) & (k units) Table 34. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2021-2026) Table 35. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2027-2032) Table 36. Global Subcutaneous Injection Immunoglobulin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Subcutaneous Injection Immunoglobulin Revenue by Application (2021-2026) & (k units) Table 38. Global Subcutaneous Injection Immunoglobulin Revenue by Application (2027-2032) & (k units) Table 39. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2021-2026) Table 40. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2027-2032) Table 41. Global Subcutaneous Injection Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Subcutaneous Injection Immunoglobulin Sales by Region (2021-2026) & (k units) Table 43. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Region (2021-2026) Table 44. Global Subcutaneous Injection Immunoglobulin Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Subcutaneous Injection Immunoglobulin Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 48. North America Subcutaneous Injection Immunoglobulin Sales by Country (2027-2032) & (k units) Table 49. Europe Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 51. Europe Subcutaneous Injection Immunoglobulin Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2027-2032) & (k units) Table 58. Global Subcutaneous Injection Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Subcutaneous Injection Immunoglobulin Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2021-2026) Table 62. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2027-2032) Table 63. Takeda Company Information Table 64. Takeda Business Overview Table 65. Takeda Subcutaneous Injection Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Subcutaneous Injection Immunoglobulin Product Portfolio Table 67. Takeda Recent Development Table 68. Grifols Company Information Table 69. Grifols Business Overview Table 70. Grifols Subcutaneous Injection Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Grifols Subcutaneous Injection Immunoglobulin Product Portfolio Table 72. Grifols Recent Development Table 73. CSL Company Information Table 74. CSL Business Overview Table 75. CSL Subcutaneous Injection Immunoglobulin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. CSL Subcutaneous Injection Immunoglobulin Product Portfolio Table 77. CSL Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Subcutaneous Injection Immunoglobulin Distributors List Table 81. Subcutaneous Injection Immunoglobulin Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Subcutaneous Injection Immunoglobulin Product Image Figure 2. Global Subcutaneous Injection Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Subcutaneous Injection Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Subcutaneous Injection Immunoglobulin Sales (2021-2032) & (k units) Figure 5. Global Subcutaneous Injection Immunoglobulin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Subcutaneous Injection Immunoglobulin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10% Purity Image Figure 9. 20% Purity Image Figure 10. Global Subcutaneous Injection Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Subcutaneous Injection Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2021-2032) Figure 13. Global Subcutaneous Injection Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Subcutaneous Injection Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2021-2032) Figure 16. Primary Immunodeficiency Image Figure 17. Secondary Immunodeficiency Image Figure 18. Others Image Figure 19. Global Subcutaneous Injection Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Subcutaneous Injection Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2021-2032) Figure 22. Global Subcutaneous Injection Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Subcutaneous Injection Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2021-2032) Figure 25. North America Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 27. U.S. Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 32. Germany Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 39. China Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Market Share by Country (2021-2032) Figure 47. Brazil Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Subcutaneous Injection Immunoglobulin Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Subcutaneous Injection Immunoglobulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Subcutaneous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 58. North America Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Subcutaneous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 60. Europe Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Subcutaneous Injection Immunoglobulin Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Subcutaneous Injection Immunoglobulin Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 10% Purity
  • 20% Purity
Applications
  • Primary Immunodeficiency
  • Secondary Immunodeficiency
  • Others
Companies covered
  • Takeda
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Subcutaneous Injection Immunoglobulin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Subcutaneous Injection Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Subcutaneous Injection Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Subcutaneous Injection Immunoglobulin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Subcutaneous Injection Immunoglobulin Market Dynamics
  1. 2.1 Subcutaneous Injection Immunoglobulin Industry Trends
  2. 2.2 Subcutaneous Injection Immunoglobulin Industry Drivers
  3. 2.3 Subcutaneous Injection Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Subcutaneous Injection Immunoglobulin Industry Restraints
3 Subcutaneous Injection Immunoglobulin Market by Manufacturers
  1. 3.1 Global Subcutaneous Injection Immunoglobulin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Subcutaneous Injection Immunoglobulin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Subcutaneous Injection Immunoglobulin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Subcutaneous Injection Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Subcutaneous Injection Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Subcutaneous Injection Immunoglobulin Manufacturers, Product Type & Application
  7. 3.7 Global Subcutaneous Injection Immunoglobulin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Subcutaneous Injection Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Subcutaneous Injection Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Subcutaneous Injection Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Subcutaneous Injection Immunoglobulin Market by Type
  1. 4.1 Subcutaneous Injection Immunoglobulin Type Introduction
  2. 4.1.1 10% Purity
  3. 4.1.2 20% Purity
  4. 4.2 Global Subcutaneous Injection Immunoglobulin Sales by Type
  5. 4.2.1 Global Subcutaneous Injection Immunoglobulin Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Subcutaneous Injection Immunoglobulin Sales by Type (2021-2032)
  7. 4.2.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Type (2021-2032)
  8. 4.3 Global Subcutaneous Injection Immunoglobulin Revenue by Type
  9. 4.3.1 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Subcutaneous Injection Immunoglobulin Revenue by Type (2021-2032)
  11. 4.3.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Type (2021-2032)
5 Subcutaneous Injection Immunoglobulin Market by Application
  1. 5.1 Subcutaneous Injection Immunoglobulin Application Introduction
  2. 5.1.1 Primary Immunodeficiency
  3. 5.1.2 Secondary Immunodeficiency
  4. 5.1.3 Others
  5. 5.2 Global Subcutaneous Injection Immunoglobulin Sales by Application
  6. 5.2.1 Global Subcutaneous Injection Immunoglobulin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Subcutaneous Injection Immunoglobulin Sales by Application (2021-2032)
  8. 5.2.3 Global Subcutaneous Injection Immunoglobulin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Subcutaneous Injection Immunoglobulin Revenue by Application
  10. 5.3.1 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Subcutaneous Injection Immunoglobulin Revenue by Application (2021-2032)
  12. 5.3.3 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Application (2021-2032)
6 Global Subcutaneous Injection Immunoglobulin Sales by Region
  1. 6.1 Global Subcutaneous Injection Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Subcutaneous Injection Immunoglobulin Sales by Region (2021-2032)
  3. 6.2.1 Global Subcutaneous Injection Immunoglobulin Sales by Region (2021-2026)
  4. 6.2.2 Global Subcutaneous Injection Immunoglobulin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Subcutaneous Injection Immunoglobulin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Subcutaneous Injection Immunoglobulin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Subcutaneous Injection Immunoglobulin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Subcutaneous Injection Immunoglobulin Revenue by Region
  1. 7.1 Global Subcutaneous Injection Immunoglobulin Revenue by Region
  2. 7.1.1 Global Subcutaneous Injection Immunoglobulin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Subcutaneous Injection Immunoglobulin Revenue by Region (2021-2026)
  4. 7.1.3 Global Subcutaneous Injection Immunoglobulin Revenue by Region (2027-2032)
  5. 7.1.4 Global Subcutaneous Injection Immunoglobulin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Subcutaneous Injection Immunoglobulin Revenue (2021-2032)
  8. 7.2.2 North America Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Subcutaneous Injection Immunoglobulin Revenue (2021-2032)
  11. 7.3.2 Europe Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Subcutaneous Injection Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Subcutaneous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Subcutaneous Injection Immunoglobulin Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Subcutaneous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Subcutaneous Injection Immunoglobulin Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 CSL
  14. 8.3.1 CSL Company Information
  15. 8.3.2 CSL Business Overview
  16. 8.3.3 CSL Subcutaneous Injection Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL Subcutaneous Injection Immunoglobulin Product Portfolio
  18. 8.3.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Subcutaneous Injection Immunoglobulin Value Chain Analysis
  2. 9.1.1 Subcutaneous Injection Immunoglobulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Subcutaneous Injection Immunoglobulin Production Mode & Process
  6. 9.2 Subcutaneous Injection Immunoglobulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Subcutaneous Injection Immunoglobulin Distributors
  9. 9.2.3 Subcutaneous Injection Immunoglobulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst